Study shows huge asymmetry in cancer clinical trials in different countries

Study shows huge asymmetry in cancer clinical trials in different countries

Study shows huge asymmetry in cancer clinical trials in different countries

Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.